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Background: Case management of imported malaria within the context of malaria pre-elimination is increasingly
considered to be relevant because of the risk of resurgence. The assessment of malaria importation would provide
key data i) to select countries with propitious conditions for pre-elimination phase and ii) to predict its feasibility.
Recently, a sero-prevalence study in Djibouti indicated low malaria prevalence, which is propitious for the
implementation of pre-elimination, but data on the extent of malaria importation remain unknown.
Methods: Djiboutian plasmodial populations were analysed over an eleven-year period (1998, 1999, 2002 and
2009). The risk of malaria importation was indirectly assessed by using plasmodial population parameters. Based on
5 microsatellite markers, expected heterozygosity (H.e.), multiplicity of infection, pairwise Fst index, multiple
correspondence analysis and individual genetic relationship were determined. The prevalence of single nucleotide
polymorphisms associated with pyrimethamine resistance was also determined.
Results: Data indicated a significant decline in genetic diversity (0.51, 0.59, 0.51 and 0 in 1998, 1999, 2002 and 2009,
respectively) over the study period, which is inconsistent with the level of malaria importation described in a
previous study. This suggested that Djiboutian malaria situation may have benefited from the decline of malaria
prevalence that occurred in neighbouring countries, in particular in Ethiopia. The high Fst indices derived from
plasmodial populations from one study period to another (0.12 between 1999 and 2002, and 0.43 between 2002
and 2009) suggested a random sampling of parasites, probably imported from neighbouring countries, leading to
oligo-clonal expansion of few different strains during each transmission season. Nevertheless, similar genotypes
observed during the study period suggested recurrent migrations and imported malaria.
Conclusion: In the present study, the extent of genetic diversity was used to assess the risk of malaria importation
in the low malaria transmission setting of Djibouti. The molecular approach highlights i) the evolution of Djiboutian
plasmodial population profiles that are consistent and compatible with Djiboutian pre-elimination goals and ii) the
necessity to implement the monitoring of plasmodial populations and interventions at the regional scale in the
Horn of Africa to ensure higher efficiency of malaria control and elimination.
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According to the World Malaria Report 2012 [1], there
were about 219 million cases of malaria (with an uncer-
tainty range [10 to 90 percentile] of 154 million to 289 mil-
lion) and an estimated 660,000 deaths in 2010 (with an
uncertainty range of 610,000 to 971,000). Malaria mortality
rates have fallen by more than 25% globally since 2000 and
by 33% in the World Health Organization (WHO) African
region [2]. Today, the WHO is considering that in some
regions characterized by favourable conditions, malaria
elimination has become a realistic goal [3-5]. As a first step,
these areas are eligible for pre-elimination stage. Local mal-
aria transmission can subsequently be interrupted in these
areas through incremental stages. A progressive decline in
malaria transmission is expected to reduce the surface area
of malaria-endemic region, country by country, from hypo-
endemic to hyper-endemic areas [6].
However, malaria control and the pre-elimination
process may be hampered by multiple insecticide and
drug resistance of mosquito vectors and malaria parasites,
respectively. In order to limit the impact of drug-resistant
malaria and prevent its spread, monitoring of drug resist-
ance is strongly recommended [5]. Moreover, imported
malaria may hamper malaria control and cause malaria re-
surgence in countries that have reached the elimination
phase [7,8]. The higher the numbers of imported cases in a
country in the pre-elimination phase, the greater will be
the risk that malaria returns and even rebounds, and more
resources for combating malaria will be required to attain
elimination [9]. Therefore, according to the incremental
elimination strategy, areas with limited cases of imported
malaria should be enlisted first in the pre-elimination
phase. When elimination is attained in those areas,
malaria elimination in neighbouring areas with higher
malaria transmission level may be considered.
Since the level of local malaria endemicity and the
number of imported cases are two key factors for the
assessment of feasibility and estimation of resources re-
quired for the pre-elimination step, national surveillance
system in a country aiming for pre-elimination should
focus on these two determinants. To that end, classical
sero-epidemiological methods as described by Corran
et al. [10] and Drakeley et al. [11] may be completed
by a population genetics approach which could take advan-
tage of the population plasticity driven by evolutionary
forces. For example, selection pressure or migrations alter
parasite populations, and these modifications in plasmodial
population would lead to genetic changes, which can be
monitored. Analysis of allelic frequencies in plasmo-
dial populations is an efficient way to describe such micro-
evolution [12-20].
As allelic frequencies within parasite populations are
summarized by genetic diversity defined by expected
heterozygosity (He), [He = [n/(n − 1)][1 − Σ
n
i = 1p
2
i] [21], thedetermination of He is an efficient way to monitor changes
occurring at the population level. Interestingly, He is
positively correlated with local malaria transmission level
[22-26]. Low local transmission levels are associated with
low He [27,28]. Conversely, high transmission levels are
associated with an increase in He [24,29]. He values may
also be associated with human migrations which appear
to be the main parasite ‘transporter and provider’ and
therefore a ‘promoter’ of genetic diversity [22,30,31], even
over long distances [32]. This is consistent with the cor-
relation observed between human migration rate and
genetic similarities among malaria parasite populations in
an archipelago model [33]. Local levels of malaria trans-
mission and the number of imported malaria cases are
therefore positively correlated with genetic diversity. Since
pre-elimination programme aims to decrease local trans-
mission level and control parasite importations, both of
these factors together should be associated with a de-
crease in plasmodial genetic diversity (He) during the
process of pre-elimination.
Additional information on the evolution of allelic fre-
quencies may be obtained from Fst index [34]. This
index may be considered as a measure of the variance in
allelic frequencies between populations [35]. Pairwise
comparison between years over a study period highlights
the global evolution and allows better understanding of
the parasite turnover rate (i.e. high pairwise Fst between
years is consistent with high turnover). Analysis of geno-
type frequencies and their similarity is also informative
to assess and determine the origin of imported malaria
cases. It may be possible to identify genetic lineage or
recurrent genotypes. In order to derive valid data
from genetic analysis, an establishment of genotype
database from eligible areas is necessary before the
pre-elimination process. In this way, it will be possible
to monitor the impact of human actions on Plasmo-
dium falciparum populations.
The Republic of Djibouti exhibits an interesting mal-
aria situation to illustrate the usefulness of population
genetics analysis within the context of malaria elimin-
ation. This country should be eligible for pre-elimination
[6,36,37]. Djibouti (geographic coordinates of Djibouti
city, the capital of the country, 11°36’N 43°10’E) [38] was
formerly known to be a meso- to hypo-endemic country
with unstable malaria [39-41]. P. falciparum and P. vivax
co-exist in the country, but the former is the predomin-
ant (> 80%) species. The major vector is Anopheles
arabiensis [1,42,43]. Its climate is semi-arid, with a mean
annual rainfall of 147 mm [38]. Over the past 12 years,
malaria incidence, as well as recurrence of epidemics,
has decreased [44]. The epidemiologic strata have been
illustrated by few micro-epidemics [32], with the excep-
tion of a major malaria outbreak that occurred in 1999
[45]. Sero-prevalence data from 2002 [43] confirmed the
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hotspots occurred on both sides of the main wadi (i.e.,
Ambouli wadi) and in the quarters of Arhiba and Balbala
4 (Additional file 1 from Khaireh et al. [43]) where large
populations of migrants who travel regularly to and/or
from Ethiopia reside [46]. Across the Republic, P. falcip-
arum sero-prevalence rates were higher in the southern
regions (Dikhil and Ali-Sabieh), particularly along the
land routes to Ethiopia, i.e., Tammiro/As-Eyla and Ali-
Sabieh (Additional file 2 from Khaireh et al. [43]). These
roads are used frequently by professional truckers, pri-
vate users, and migrants because they are the only two
roads connecting Djibouti and Ethiopia [47].
Recently, a national sero-prevalence investigation includ-
ing 7,151 individuals (from November 2008 to January
2009) throughout the country (150 clusters of 75 house-
holds from the capital [40%] and districts [60%]) confirmed
the very low malaria prevalence (0.58%) [48]. National
sero-prevalence data are consistent with the decrease
in malaria incidence monitored by three main medical
services in the city of Djibouti (Additional file 3) where al-
most two-thirds of the population reside (61.7%, according
to the official Djiboutian publication of census [49]). Con-
sidering this high Djiboutian urbanization and movement
of people between the capital and the rest of the country
[49], this correspondence between inside and outside the
capital was expected. After the outbreak in 1999, the first
decrease in malaria incidence occurred in 2001 (4-fold de-
crease) and the second decrease in 2006 (11-fold decrease)
(Additional file 3). Although the decrease in malaria
burden was in favour of the Djiboutian eligibility for
pre-elimination step, there are no field data on the risk of
malaria importation that could hamper the elimination
process. In order to adapt malaria control programme in
this country, it would be useful to characterize the circulat-
ing P. falciparum isolates in Djibouti and importations
from neighbouring countries.
In the late 1980s, a study showed multiple events of
malaria importation from neighbouring countries [41].
Moreover, previous molecular data suggested the exist-
ence of parasite exchange sufficient to provide a moder-
ate genetic diversity [32,45], despite seasonal interruption
of local malaria transmission [39,45]. However, the actual
extent of imported malaria remains unknown. What
is the genetic diversity of imported malaria? What is
the parasite turnover rate? The success of the pre-
elimination programme will depend, in part, on the
responses to these questions.
To complete the understanding of Djiboutian malaria
epidemiologic strata within the context of malaria pre-
elimination, an indirect genetic approach was adopted.
Analyses of genetic diversity, as well as those of rela-
tionships among parasites collected over a period of
11 years, shed light on the above-mentioned questions.Multilocus microsatellite genotyping was performed in
P. falciparum isolates collected over 11 years (1998, 1999,
2002, and 2009). Based on WHO recommendations
on drug resistance monitoring [3,5] and the fact that
sulphadoxine-pyrimethamine is the current partner
molecule of artesunate (artemisinin-based combination
therapy [ACT]) for the first-line treatment employed in
Djibouti since 2008 [50], polymorphisms associated with
resistance to pyrimethamine were also genotyped.
Methods
Plasmodium falciparum isolates
Isolates were collected four times over an 11-year period
(1998, 1999, 2002, and 2009). The first three investiga-
tions were conducted at the Centre Hospitalier des
Armées Bouffard, a French military hospital in Djibouti
city serving Djiboutian military and native civilians
residing in the city, and other public health facilities
in Djibouti city. Blood samples were collected from
symptomatic patients with P. falciparum who had not
travelled outside the city of Djibouti during the pre-
ceding month and who denied self-medication with
an anti-malarial drug before consultation. Forty-six
blood samples were collected between September and
December 1998, 61 in April 1999, and 32 between
March and May 2002. Venous blood (5 mL) was col-
lected in ethylene diamine tetra acetic acid (EDTA)-
coated Vacutainer® tubes (Becton Dickinson, Rutherford,
NJ, USA). Aliquots of freshly collected blood were kept
at −20°C until DNA extraction. In 2009, during the
fourth investigation, 42 samples were provided by the
Djiboutian Malaria Control Unit (Ministry of Health).
These samples, collected during an investigation of malaria
seroprevalence detailed elsewhere, were obtained from
three sites outside Djibouti city: Arta, Tadjourah, and
Obock [48] (Figure 1). One blood sample was obtained
from a Djiboutian military recruit who presented with
clinical malaria in January 2009 after staying at the mili-
tary training camp in Debrezeit (Ethiopia) for 10 months
prior to blood collection. Three additional isolates from
Ethiopia sampled in 2008 were provided by the Depart-
ment of Parasitology and Vector Borne Diseases (Ethiopian
Health and Nutrition Research Institute).
Blood samples were spotted onto Whatman® 3 MM fil-
ter paper, and all samples were frozen and kept at −20°C
in the national laboratory at Hôpital General Peltier in
Djibouti city. The study was cleared and approved by
the Djiboutian Ministry of Health (authorization no. 48/
INSP/MS/2012). Informed consent was obtained from
all patients before blood collection. Sampling details on
geographic location and sampling period are described
elsewhere [48]. The characteristics of laboratory-confirmed
P. falciparum malaria at four different time points are
summarized in Figure 1.
Figure 1 Locations of Plasmodium falciparum-positive cases sampled in the Republic of Djibouti (1998, 1999, 2002, and 2009)
Sampling sites where Plasmodium falciparum cases were diagnosed with rapid diagnostic tests and confirmed by PCR. Forty-six blood
samples were collected from September to December 1998 (red dot), 61 in April 1999 (blue dot), and 32 from March to May 2002 (light green
dot) from symptomatic patients with P. falciparum who had not travelled outside the city of Djibouti during the preceding month and declared
not to have taken any antimalarial drug before blood sampling. In 2009, 42 Djiboutian samples were collected from November 2008 to January
2009 by the Djiboutian Malaria Control Unit (Ministry of Health) (khaki green) [48]. One blood sample was obtained from a Djiboutian military
recruit who presented with clinical malaria (purple dot) in January 2009 and who stayed at the training camp in Debrezeit (Ethiopia) for
10 months prior to blood collection. Three blood samples provided by the Department of Parasitology and Vector Borne Diseases (Ethiopian
Health and Nutrition Research Institute) were collected in Southeast Ethiopia (dark green dot) in 2008. According to the official census of
Djiboutian population, Djibouti exhibits a high urbanization rate. Djibouti city, Ali Sabieh, Dikhil, Tadjourah, Arta, and Obock account for 62%, 11%,
10%, 9%, 5%, and 4% of the national population, respectively [49].
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DNA was extracted from filter papers and frozen whole
blood using EZNA blood DNA kit (Biofidal, Vaulx-
en-Velin, France) according to the manufacturer’s recom-
mendations. Microsatellite genotyping was performed
by amplification fragment length polymorphism (AFLP)
analysis. Five complex and putatively neutral microsat-
ellite loci [32] (Pf2689, 7A11, C4M79, Pf2802, and TRAP)
were amplified by nested PCR with fluorescent end-labelledprimers, as described previously [32]. Thermocycling was
performed using a Biometra (Goettingen, Germany) 96-
well T1 thermocycler. The accession numbers and primer
sequences are summarized in Table A (Additional file 4).
Single nucleotide polymorphisms (SNPs) of P. falcip-
arum dihydrofolate reductase (Pfdhfr) gene at codons
16, 51, 59, 108, and 164 associated with resistance to
pyrimethamine and cycloguanil (i e, the biologically ac-
tive metabolite of proguanil [51]) were determined using
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earlier study [52]. The accession numbers are presented in
Table A (Additional file 4).
AFLP and SNaPshot® products were analysed by capil-
lary electrophoresis on polyacrylamide gels using ABI
3130XL® sequencer (Applied Biosystems®, Warrington,
UK). Electrophoregram was interpreted using Genemapper®
4.0 software (Applied Biosystems®, Carlsbad, CA, USA).
Statistical analysis
The multiplicity of plasmodial infection (MOI, defined
as the number of genetically distinguishable parasites
per isolate) was estimated for each isolate from the
microsatellite locus that exhibited the highest number of
alleles. The mean MOI for each collection year of P.
falciparum population (1998, 1999, 2002, and 2009) was
calculated.
The evolution of genetic diversity among Djiboutian
P. falciparum populations is dependent on local trans-
mission level and parasite flow, a source of genetic
diversity. Genetic diversity was assessed by the Nei
unbiased expected heterozygosity index [21], He = [n/
(n − 1)][1 − Σn i = 1p
2
i] (where n is the number of iso-
lates sampled and pi is the frequency of the ith allele)
and calculated from allelic frequencies of five micro-
satellite loci using GENETIX software version 4.05
[53]. Pairwise comparisons of He values among the
four collection periods were performed using FSTAT
software version 2.9.4, with a 10,000 permutations
bilateral comparison test [54].
Genetic similarity of plasmodial populations was
investigated using Wright F statistic (FST) [34]. Pairwise
comparisons among the collection years (1998, 1999,
2002, and 2009) were performed based on microsatel-
lite genotype frequencies using FSTAT software version
2.9.4 [35,54]. FST is a comparison of the sum of genetic
variability within and between populations based on
the differences in allelic frequencies. FST values were
interpreted as no differentiation (0), low genetic differ-
entiation (>0 - 0.05), moderate differentiation (0.05-
0.15), and high differentiation (0.15-0.25).
Multiple correspondence analyses (MCA), also known as
factorial correspondence analysis (FCA) [55] according to
multilocus genotypes, were conducted to illustrate the gen-
etic similarity of plasmodial populations during the study
period. FCA was performed by considering population
centroids as active points, using GENETIX software, as
described in the help menu [53]. The graphical representa-
tion with 95% data concentration ellipse (i e, including 95%
of the projected genotypes on the FCA plan) and centroids
was obtained using R software, version R 2.15.1 [56].
The relationships between parasite genotypes were
assessed using eBurst algorithm. Based on microsatellite
allelic profiles, the algorithm selects the most parsimoniouspatterns of genotype evolution and predicts founder(s).
The assignment of founders is tested by a bootstrap pro-
cedure [57]. The global optimization of the diagram based
on goeBurst algorithm [58] was performed with Phyloviz
software [59]. The eBurst algorithm implements a simple
model of clonal expansion and diversification which is gen-
erally used to represent a population of clonal prokaryote
[57]. Despite its obligatory sexual stage, P. falciparum may
evolve as a clonal organism due to inbreeding [30,60-65].
A high self-fertilization rate (i.e. syngamy between genetic-
ally identical gametes) may be favoured in low malaria
transmission settings [24,25,30,66]. Outbreaks are an
extreme situation where the oligo-clonal spreading of
parasites (i e, only few plasmodial populations propagate
during epidemics) may occur [67-69]. As malaria epi-
demics had occurred in Djibouti with oligo-clonal expan-
sion of plasmodial populations [32,45], eBurst diagram is
particularly well adapted for the description of Djiboutian
malaria situation.
Comparison between the global unstratified eBurst
diagram and eBurst diagram stratified by the sampling
year was performed to assess the robustness of eBurst
algorithm.
The index of discriminatory power (D) was assessed in
order to estimate the discriminatory power of the genotyp-
ing based on four microsatellite loci. This index is calcu-
lated from the number of genotypes and their relative
frequencies. The index D is the probability that two unre-
lated parasites randomly sampled from studied population
display different genotypes. By analogy with Nei unbiased
expected heterozygosity index (He), D is an indirect meas-
ure of genotypic diversity. According to Hunter and
Gaston’s formula [70], D = 1 − 1/(N(N − 1)) ΣS j = 1nj(nj − 1)
where N is the total number of parasites in the sample
population, s is the total number of genotypes observed,
and nj is the number of strains with the jth genotype.
Results
Genetic diversity
When the combination of the profiles at five microsatellite
loci was considered, 57, 66 and 43 genotypes were success-
fully obtained from 46, 61, and 32 samples collected in
1998, 1999, and 2002, respectively. Among 42 samples
collected in 2009, the Pf2802 locus did not show enough
profiles to perform analysis. The low success rate of Pf2802
genotyping was probably due to: i) the longer amplified
fragment by the first PCR that is more sensitive to the
quality of DNA template, or ii) the presence of null allele
in oligo-clonal plasmodial populations. Therefore, the
combination of the profiles at four microsatellite loci was
considered, and 36 genotypes were observed in 2009.
Based on the microsatellite loci, a moderate genetic di-
versity (He) was observed during the four-year period from
1998 (He = 0.51 ± 0.20) to 2002 (He = 0.51 ± 0.14). At the
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and there was no observable genetic diversity (He = 0).
The MOI showed a similar pattern, starting from the
baseline mean (± SD) MOI of 1.86 ± 0.81 in 1998 to the
MOI value of 1.0 in 2009. This result is particularly note-
worthy, considering that the isolates were sampled in 2009
from three areas outside Djibouti city (Arta, Tadjourah,
and Obock) during an interval of only a few weeks.
The numbers of alleles by locus that estimate the
number of distinct genotypes were 7.8, 8.4, 6.0, and 1.0
in 1998, 1999, 2002, and 2009, respectively. These results
suggested a similar tendency as MOI and He values. The
results on genetic diversity, MOI, and numbers of alleles
are summarized in Table 1.
Parasite genetic similarity: population and individual
analysis
The pairwise comparisons of plasmodial populations
among different years of sample collection displayed sta-
tistically significant differences in Fst indices (Fst >0.12),
except between 1998 and 1999 (Fst = 0). The highest Fst
index (>0.39) was observed between the isolates in 2009
and those collected during the preceding years. Contigu-
ous centroids and superimposed ellipses of plasmodial
populations in 1998 and 1999 were obtained (Figure 2).
Plasmodial population in 2002 appeared dissimilar from
the other three populations (Fst > 0.12).
Genotype relationships provide additional information
about individual relationships and yearly genotype turn-
over (Figure 3). Based on the analysis of four microsatel-
lite loci, a total of 62 P. falciparum genotypes were
detected in the present study. Clustering among the iso-
lates collected during the same year was consistent with
significant Fst indices between different years. During
the 11-year period, the present data exhibited 10, 18, 10,
and 0 private genotypes observed only in 1998, 1999,
2002 and 2009, respectively (2 genotypes observed only
in 2008 were sampled in southeast Ethiopia). However,
16 genotypes were present across several study periods.
Among these, 12 genotypes observed in 1998 were still
present in 1999. Major genotypes were even present forTable 1 Genetic diversity of Plasmodium falciparum and evolu
Djibouti (1998–2009)
Populations Microsatellites, individual He
n 7A11 C4M79 Pf 2689 Pf 2802
1998 46 0.5427(72) 0.2838(57) 0.3163(62) 0.6944(66
1999 61 0.5835(76) 0.4585(66) 0.4381(75) 0.7336(80
2002 32 0.4493(47) 0.1762(43) 0.4615(46) 0.7281(46
2009 42 0(42) 0(41) 0(42) NA
He, Nei unbiased expected heterozygosity index; SD standard deviation, MOI multip
results detected. The number of genotypes successfully obtained is in parentheses.three or four years. Genotype 32 was present in 1998,
1999, and 2002 and also occurred among imported mal-
aria parasites from Ethiopia in 2008 (Figures 3 and 4).
Genotype 38 also occurred in 1998, 1999, and 2002.
Moreover, genotypes were closely-related from year to
year. Most of the new genotypes differed at only one
locus from genotypes that were observed in earlier years
(i e, single-locus variant, SLV). The global, unstratified
eBurst diagram, without considering the year of sam-
pling, involved only five double-loci variants (DLVs).
In 2009, all Djiboutian isolates exhibited identical
genotypes at four microsatellite loci (PF2689, C4M79,
TRAP, and 7A11). This genotype, i e, genotype 36, was
observed earlier in 1998. Genotype 27 observed in P. fal-
ciparum isolated from a Djiboutian military recruit who
stayed in a military training camp in Debrezeit (Ethiopia)
(8° 45‘ 00“ N 38° 59‘ 00“ E) for 10 months in 2009 was
observed earlier in 1999. Ethiopian genotypes found in
the present study were either similar to Djiboutian geno-
types (genotype 32) or differed by only one locus from
Djiboutian genotypes (genotypes 39 and 46).
Eburst diagram stratified by the year of detection
(Figure 4) showed a similar pattern, with two major geno-
types (genotypes 38 and 32) linked to numerous SLVs. This
analysis avoided few links between years that had probably
not occurred (13 links were modified) and pointed out
more clearly the diversification of genotypes over time.
Based on the eBurst diagrams of parasites collected in
1998 and 1999, six (genotypes 2, 17, 27, 37, 48, and 54)
and five (genotypes 5, 22, 24, 59, and 62) new SLVs
emerged in 1999 from genotypes 32 and 38, respectively.
Despite this diversification, genetic lineage (56, 38, 32, 49,
51, and 61) was maintained from year to year, and major
genotypes were similar (genotypes 32 and 38). To a lesser
extent, in 2002, diversification occurred from an earlier
major genotype (32).
Based on the frequencies of 62 genotypes observed
among 225 parasites, the index of discriminatory power
(D) [70] was 91%. The index D by year was 0.87, 0.89,
and 0.89 for 1998, 1999, and 2002, respectively. Despite
the closely-related genotypes and even recurrent genotypestion of multiplicity of infection (MOI) in the Republic of
Mean He MOI Mean number of
alleles/ locus
TRAP [±SD] [±SD]
) 0.7060(66) 0.5086[±0.20] 1.36[±0.81] 7.8
) 0.7245(81) 0.5876[±0.14] 1.42[±0.79] 8.4
) 0.7467(47) 0.5124[±0.23] 1.12[±0.38] 6.0
0(36) 0 1.00 1.0
licity of infection mean number of alleles/locus, n, number of samples, NA, no
Figure 2 Analysis of genetic similarity between Djiboutian Plasmodium falciparum populations (1998, 1999, 2002, and 2009)
Plasmodium falciparum populations in Djibouti (1998 red dot, 1999 blue dot, 2002 light green dot, and 2009 khaki dot; sampling
details are presented in the text and Figure 1) were compared based on the genotyping of four microsatellites. Pairwise Fst indices
between the years studied are presented in the table at the top left. Statistically significant Fst values (P < 0.05) are underlined. Multiple
correspondence analysis (also called factorial correspondence analysis) was performed with Genetix software [53], using populations’ centroid as
the active point. Axes FCA I and FCA II are the first two order factors representing 51.7% and 42.4% of the total inter-centroid variance,
respectively. Ellipses around the centroids enclose 95% of the projected genotypes on the FCA plan and were calculated and graphically
represented using R software [56]. Genotype frequencies in 2009 did not allow ellipse representation.
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parasite populations on a fine scale.
Evolution of drug resistance: mutations associated with
pyrimethamine resistance
Genotyping of all five Pfdhfr codons (16, 51, 59, 108 and
164) associated with pyrimethamine resistance was suc-
cessful in 36 of 46 (78%), 50 of 61 (82%), and four of 32
(12.5%; only five samples were available after microsatellite
study [32]) samples collected in 1998, 1999, and 2002, re-
spectively. Thirteen of 42 (31%) samples obtained in 2009
were successfully genotyped, with the exception of codon
51. The prevalence of mutations in relation to the study
periods is summarized in Table 2.
In 1998, there was no triple mutant (defined as N51I,
C59R, and S108N) and only one isolate (2.8%) carried
C59R and S108N amino acid substitutions. In 1999, two
(4%) isolates were triple mutants. In 2002, the preva-
lence of triple mutants dropped back to 0%. On the con-
trary, 13 (100%) isolates were double mutants (C59R
and S108N) in 2009.
Discussion
In this present study, genetic diversity was analysed and
applied in innovative ways to assess the risk of malaria
importation into low malaria transmission settings. Basedon the results of microsatellite allele frequencies, the
present study highlights an important modification in
Djiboutian P. falciparum population. First, a moderate gen-
etic diversity (He = 0.51) was observed from 1998 to 2002,
with a slight increase in 1999 (He = 0.59). These results are
in agreement with antigenic data and previous microsatel-
lite analysis, which showed a similar level of genetic diver-
sity (He = 0.53) [32]. Secondly, at the end of the study
period, a significant decline in genetic diversity was
recorded (He2009 = 0). This diminution is all the more im-
portant because, in 2009, mass screening for malaria was
conducted over a period of three months in 150 sites
throughout the country, and P. falciparum-positive cases
were found in only three sites. These three sites are sepa-
rated by hundreds of kilometres (by road), as compared
with samples collected before 2009, which originated from
Djibouti city only. In this context, the sampling bias
in 2009 should have resulted in an opposite trend.
The evolution of genetic diversity is confirmed by a similar
reduction in the numbers of alleles (7.8 to 1) and the
decrease in MOI at the microsatellite loci analysed during
the study period.
Concerning the association between the local level of
malaria transmission and plasmodial population parame-
ters, such as genetic diversity and MOI [24,27,29,71-73],
the observed significant decrease in malaria transmission
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Figure 3 Genetic relationship between Djiboutian Plasmodium falciparum genotypes observed at four time points (1998, 1999, 2002,
and 2009). Unstratified analysis that does not take into account the year of sampling. This graphical representation of relationships
between closely-related genotypes of Plasmodium falciparum is based on eBurst algorithm [57]. A global optimization selects the more likely
evolutionary pattern and highlights potential ancestral (or founding) genotype(s) of cluster of closely-related genotypes [58,59]. A total of 62
genotypes were found (numbers 1 to 62). A separation level between two distinct genotypes is represented by i) a solid line, a different profile in
only one locus of microsatellite marker, i e, single-locus variant (SLV) and ii) a dotted line, a double-loci variant (DLV). The distance between
genotypes in the diagram does not have any relation with genetic distance between genotypes. The area of circles depends on the number of
individuals with the same genotype. The colour code is as follows: 1998 (red dot), 1999 (blue dot), 2002 (light green dot), and 2009 (khaki dot). In
2009, three malaria cases originated from Southeast Ethiopia (dark green dot) and one from Debrezeit, Ethiopia (purple dot). The proportion of
each colour inside one circle depends on the number of individuals with the same genotype for the year considered. Red lines indicate
relationships that are modified in stratified analysis.
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http://www.malariajournal.com/content/12/1/201in Djibouti is in agreement with the results of the recent
sero-epidemiological study [48]. Interestingly, such a de-
crease in genetic diversity is not consistent with the level of
malaria importation reported previously [32,41]. So far,
even with an interruption of local malaria transmission for
several months during the dry season, a long-term carriage
of P. falciparum [71,74] and, more probably, imported
malaria cases were able to maintain an intermediate diver-
sity level [0.51 <He1998-1999–2002 < 0.58] [32]. Therefore, the
absence of genetic diversity i) confirms the decline in thelevel of local malaria transmission, and ii) strongly suggests
a reduction of imported malaria cases in Djibouti. These
observations highlight the likely benefits of a coordinated
malaria control programme with the neighbouring coun-
tries [75-77]. Since Ethiopia is the main source of imported
malaria cases in Djibouti due to geographic proximity and
socio-epidemiologic context [39,41,78], a successful Roll
Back Malaria Programme in Ethiopia is expected to lower
the number of imported malaria cases from Ethiopia
to Djibouti.
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http://www.malariajournal.com/content/12/1/201Based on the analysis of genotype frequencies, a high Fst
index (>0.15) and distant centroids (Figure 2) between
sampling years strongly support a considerable plasmodial
population turnover during the study period. These clus-
ters at different time points may be attributable to sub-
sampling of plasmodial populations from neighbouring
countries (in particular Ethiopia) through human migra-
tion. As this random sampling occurred each year, the
source of different strains involved in epidemics may vary
over time. As fewer parasite strains are imported into
Djibouti, the allelic frequencies in plasmodial populations
will be less stable due to genetic drift. This phenomenon isTable 2 Evolution of the prevalence of Pfdhfr point mutation
51 59
N (Asn) (W) I (Ile) (M) C (Cy
Year N AAT ATT TGT
1998 36 100 0 97.2
1999 50 96.0 4.0 94.0
2002 4 100 0 100
2009 13 NA NA 0
Proportions (%) of single nucleotide polymorphism are presented: Pfdhfr Plasmodiu
result at one codon; W wild-type, M mutant. NA; no results detected. Codons 16 anconsistent with an increase in Fst recorded from 1999 to
2009 (Fst(1999 vs 2002) =0.129 and Fst(2002 vs 2009) = 0.426).
Conversely, a statistically non-significant Fst and con-
tiguous centroids between 1998 and 1999 observed dur-
ing an earlier malaria situation in Djibouti are consistent
with a more stable population. This particular result in
1998–1999 is probably due to i) residual malaria foci in
Djibouti, leading to genetically similar populations as the
source of yearly epidemics, and/or ii) higher numbers of
imported malaria cases from neighbouring countries,
leading to an increased genetic exchange in plasmodial
populations from different countries. These observationss in codons 16, 51, 59, 108, and 164
108
s) (W) R (Arg) (M) S (Ser) (W) N (Asn) (M)
CGT AGC AAC
2.8 97.2 2.8
6.0 92.0 8.0
0 100 0
100 0 100
m falciparum dihydrofolate reductase, N, number of samples with at least a
d 164 showed only wild-type codons in all years studied.
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http://www.malariajournal.com/content/12/1/201lead to the hypothesis that Djiboutian plasmodial popu-
lations were more stable in 1998–1999. The analysis of
genetic relationship showed closely related genotypes,
and even similar genetic lineages, between these two
years. The two most recurrent genotypes occurred nine
and seven times for genotype 32 and 23 and 23 times for
genotype 38 in 1998 and 1999, respectively (Figure 3
detailed in Additional file 5, Table B). To a lesser extent,
similar genotypes were observed between 1999 and 2002,
which suggested a common source of Djiboutian strains
despite the random annual turnover due to sampling and
genetic diversification (Figure 4). This data interpretation is
in agreement with recurring human migratory flows across
Djiboutian borders, including regular visits to Ethiopia [78]
and transport of goods and persons via the international
Djiboutian port [79].
The decline in genetic diversity in 2009 is due to unex-
pected genotype frequencies. Only one genotype was found
in Djibouti in that year. In fact, after sampling 150 sites
throughout the country, P. falciparum had been found in
three distant sites. Taking into account both the time inter-
val (three months) between isolate collection and distance
separating the sites, identical genotypes should not be con-
sidered as the same strains but rather that they probably
represent similar plasmodial populations. Moreover, geno-
typing analyses were performed with only five or even four
microsatellite loci. Additional loci could have detected
more genotypes. Nevertheless, i) the molecular system de-
scribed in the present paper already attained a discrimin-
atory index of 91% [70] and ii) as the same microsatellite
markers were used throughout the 11-year study period,
the present data strongly indicate a significant decrease in
genetic diversity in Djibouti.
It is important to note that malaria epidemics charac-
terized by a random clonal expansion of few plasmodial
populations may lead to a rapid spread of drug resist-
ance throughout the country. Indeed, all isolates col-
lected in 2009 carried single nucleotide polymorphism
(SNPs) associated with pyrimethamine resistance at codons
59 and 108. As the Djiboutian national anti-malarial drug
policy relies on artesunate-sulphadoxine-pyrimethamine
(AS-SP) combination for the first-line treatment of uncom-
plicated malaria, the field data presented in this paper raise
the question of the necessity for a change in drug policy if
molecular data are confirmed by poor clinical and parasito-
logical response to AS-SP. However, it should be noted
that i) these high percentages of dhfr double mutants are
based on the analysis of a limited number of isolates and
triple mutants have not been observed for the past 10 years
in Djibouti, and ii) the observed mutants most likely reflect
random fluctuations due to imported strains, as opposed
to a sustained increase in the prevalence of dhfr mutants
which would have been expected if local Djiboutian dhfr
mutants had been selected and maintained under constantdrug pressure. Molecular studies in southern Ethiopia have
shown that double N51I/S108N (46%) and triple N51I/
C59R/S108N dhfr mutants (54%) predominate in Jimma,
while a large majority (>90%) of isolates are triple dhfr mu-
tants in Dilla and Gambo [80-82]. Further molecular stud-
ies in Ethiopia closer to the Djiboutian border are required
for the evaluation of imported malaria and spread of drug
resistance in Djibouti. The results of the present study
should be interpreted in the light of the prevalence of dhfr
mutants in neighbouring countries, which may be inform-
ative to assess the risk of the spread of sulphadoxine-
pyrimethamine resistance during the next epidemics
in Djibouti.
Recent studies have used molecular tools to monitor
plasmodial populations in regions of declining endemicity
following malaria control effort or in areas of naturally low
level malaria transmission ([28,69,83-86]). The most strik-
ing finding of the present study, the “clonal expansion” ob-
served after a decline in malaria transmission, is consistent
with these previous studies. Clonal expansion may occur in
low transmission settings [28,61,66,69,83,87] and may be
favoured by control efforts [69,84,85]. Considering the glo-
bal decline in malaria prevalence over the last decade [1],
more situations exhibiting epidemic or clonal expansion of
parasites can be expected in the future.
The relations a between decline in malaria transmis-
sion and variations in parasite population parameters
showed contradictory results, and more field data are
required to establish a solid relationship between these in-
dices and malaria situation. An expected decline in genetic
diversity (He) shown in the present study (Additional
file 6) was not observed in another recent study conducted
in Thailand even after a considerable reduction in malaria
transmission [88]. In western Kenya, a decrease in trans-
mission has led to an increase in genetic diversity [86]. Epi-
demiological context and migration of human population
might explain some of these discordant results. However, a
comparison of results of the present study with those of
other recent studies which used different molecular tools
(SNP vs microsatellites) and different indices to monitor
parasites should be interpreted with caution.
According to Nkhoma et al. [88], index based on MOI
(i e, percentage of polyclonal infection) seems to be more
robust or less sensible to genetic diversity resulting from
migration into a study area. These authors have found a
high correlation (coefficient of determination, r2 = 0.7967)
between malaria incidence and proportion of polyclonal
infections based on 96xSNP genotyping [88]. A high co-
efficient of determination (r2 = 0.99) has also been observed
using SNP data [66]. The data presented in this paper (four
time points, including one outbreak in 2009) did not allow
a reliable estimation of correlation (r2 = 0.59, Additional
file 7). Moreover, indices based on microsatellite loci
and comparability with SNP have not been established.
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ies confirm a decrease in the percentage of polyclonal
infections after a decline in malaria transmission [85].
Indices which take into account the genetic linkage
disequilibrium (standardized index of association, geno-
type richness, and genotypic diversity) also show correl-
ation with a decline in malaria transmission [85,88].
However, the self-fertilization rate of P. falciparum is
largely unknown, which hampers the full understanding
of these complex relations. Despite these limitations,
analysis of relationship between closely-related geno-
types in low malaria transmission settings may highlight
various evolutionary patterns, such as clonal expansion,
diversification, selection, migration, and residual foci,
that could be modified by an intervention of malaria
control programmes. Therefore, analysis of relationship
between genotypes can be a powerful complementary
tool to monitor Plasmodium populations, especially dur-
ing pre-elimination and elimination phases.
Conclusions
Molecular tools for population genetics analysis play an
increasingly important role in monitoring the character-
istics of P. falciparum populations. On the basis of a
positive correlation between local malaria transmission,
imported malaria cases and plasmodial genetic diversity,
the latter was used in innovative ways to assess the risk
of malaria importation into Djibouti, which is a low
malaria transmission setting. The significant decrease
in He, in unexpected proportions, suggests a signifi-
cant decrease in local malaria transmission as well as
in imported malaria. The present results indicate an
evolution of Djiboutian plasmodial populations towards
a malaria situation that is favourable for malaria elimin-
ation due to the presence of a few genetically distinct
strains originating from the same source and spreading
throughout the country. In this context, an efficient
surveillance system and case management will play a
major role to attain malaria elimination. Moreover, the
knowledge on the geographic origin of strains would be
helpful to target malaria control at the regional scale.
To that end, additional molecular data from neighbouring
countries, in particular from Ethiopia, are necessary. To
limit additional cost required for molecular investigations,
such molecular studies can use biological materials that
have already been sampled (e g, RDTs for malaria and thick
smear) as part of the regular activities of malaria control
units in the region, provided that prior consent from
patients had been obtained. Moreover, standardization of
protocols (DNA extraction, genotyping and microsatellite
panel) is necessary to allow direct comparison among stud-
ies and strengthen national monitoring systems in the
region for a coordinated malaria control effort in the Horn
of Africa.Additional files
Additional file 1: Classes of P. falciparum seroprevalence (%).
Additional file 2: Clusters localisation in the districts of the country.
Additional file 3: Numbers of malaria attacks within Djibouti city
from 1998 to 2009 based on three largest Djiboutian surveillance
systems: i) Peltier General Hospital (dotted squares), ii) Djiboutian
National Healthcare Insurance Program (solid squares), and iii)
Bouffard French Military Hospital (hatched squares) (adapted from
Ollivier et al. 2011). Colours (red, blue, green, and purple) highlight
the years with samples genotyped in the present study.
Additional file 4: Table A. Primer sequences and amplification conditions
of the 5 microsatellite loci and Pfdhfr: Primer sequences (5‘→ 3‘) are given for
reactions no. 1 (first round) and no. 2 (second round) of the nested PCRs with
fluorescent label (VIC, NED, 6-FAM or PET) and annealing temperature (Ta,°C).
Thermal cycling was performed using Biometra® (Goettingen, Germany)
96-well T3 thermocycler. Size in basepairs for 3D7 reference clone. Pfdhfr,
P. falciparum dihydrofolate reductase; Chr, chromosome.
Additional file 5: Table B. Number of distinct genotypes of P. falciparum
and years based on genotyping with 4 microsatellites. MIS: Samples from
Malaria Indicator Survey (described in Figure 1), D: samples from a clinical
case of Djiboutian military recruit (described in Figure 1), E: South-East
Ethiopian samples (described in Figure 3). Genotypes 32, 34, 36, and 38
constituted the largest number of Djiboutian isolates.
Additional file 6: Malaria incidence and genetic diversity in Djiboutian
P. falciparum population. The estimation of malaria incidence was based
on the three largest Djiboutian surveillance systems (details in the text and
Additional file 3). The calculation of genetic diversity (He) based on four
microsatellite genotyping is described in material and methods section. The
coefficient of determination r2 (r2 = 0. 9527;y = 0.1557ln(x) - 0.4437) suggests a
positive non-linear relation between genetic diversity (He) and malaria
incidence in the Republic of Djibouti. The linear coefficient of determination
was lower (r2 = 0.5047).
Additional file 7: Malaria incidence and percentage of polyclonal
infections in Djiboutian population of Plasmodium falciparum (1998,
1999, 2002, and 2009). The estimation of malaria incidence was based
on three largest Djiboutian surveillance systems (details in the text and
Additional file 3). The percentage of polyclonal infections (i e, infection
with multiple alleles at one or more of the four microsatellite loci) was
based on the analysis of four microsatellites.
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